Research ArticleCancer

High-dose vitamin C enhances cancer immunotherapy

See allHide authors and affiliations

Science Translational Medicine  26 Feb 2020:
Vol. 12, Issue 532, eaay8707
DOI: 10.1126/scitranslmed.aay8707

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • RE: High-does Vitamin C
    • Gerd Wasser, retired specialist for Internal Medicine, Prof. h.c. Henan University, First Peoples Hospital Zhenzhou, Henan Provinz, China

    Vitamin C acts under physiological dosages as an antioxidant and works in the soluble, aqueous phase. Oxidized Vit C will get regenerated by the fat soluble Vit E which in turn is transformed from the oxidized stage into the reduced one by the Glutathione oxidase/reductase.
    Thus, if one exceeds the regenerative capacity of the next compound (here Vit E) an overload of oxidized Vit C stays in action as a radical. Since tumours lack the antioxidative capacity needed to survive in a chronic low oxygen environment radiation and conventional chemotherapy work by inducing oxygen radicals.
    This might also be the effect if Vit E administered in lung tumours shortens the life expectancy.

    Competing Interests: None declared.

Stay Connected to Science Translational Medicine

Navigate This Article